- Tytuł:
- Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial
- Autorzy:
- Źródło:
- In The Lancet Oncology May 2023 24(5):535-552
Czasopismo naukowe